Non-Hodgkin's lymphoma (NHL) is a type of cancer that affects the lymphatic system, which is part of the immune system. It is one of the most common cancers in the United States, affecting more than 72,000 people each year. The good news is that many people with NHL can be cured.
Prognosis of Non-Hodgkin's Lymphoma
The prognosis of non-Hodgkin's lymphoma depends on a number of factors, including the type and stage of the cancer, a person’s age and overall health, and the type of treatment they receive. People with early-stage, localized NHL have the best chance for a cure. The overall five-year survival rate for NHL is 72%.
Treatment Options for Non-Hodgkin's Lymphoma
Treatment options for NHL include chemotherapy, radiation therapy, and targeted therapy. For people with early-stage, localized NHL, chemotherapy and radiation therapy may be enough to cure the cancer. For people with advanced-stage NHL, more aggressive treatments may be needed, such as stem cell transplantation or immunotherapy.
Can You Fully Recover from Non-Hodgkin's Lymphoma?
The answer to this question depends on many factors, including the type and stage of the disease, the type of treatment received, and the person’s overall health. In general, people with early-stage, localized NHL have the best chance for a full recovery. With the right treatment, many people with NHL can be cured.